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Genomic Imprinting Contributes to Thyroid Hormone
Metabolism in the Mouse Embryo
controlling prenatal growth, the development of particu-
lar lineages, and postnatal well being. These pathways
include those involving the protein-coding imprinted
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Thyroid hormones control essential functions in verte-Cambridge CB2 3DY
United Kingdom brate development and metabolism. Types 1, 2, and 3
iodothyronine deiodinases (D1, D2, and D3, respec-2 Division of Bioscience
Graduate School of Environmental Earth Science tively) constitute a group of enzymes that metabolize
thyroid hormones and thus regulate their levels in manyHokkaido University
Kitaku tissues. D3 catalyzes 5-deiodination of the inner ring,
a process that degrades both T4 and T3 to inactiveSapporo 060-0810
Japan derivatives [3]. Therefore, D3 activity may serve to pro-
tect developing tissues, especially in the fetal and neo-
natal periods, from excessive amounts of thyroid hor-
mones [4]. The human gene for this enzyme (DIO3) isSummary
mapped on chromosome 14q32 [5] and is positioned
870 kb downstream of the two imprinted genes, DLK1Many genes subject to genomic imprinting function in
and GTL2 [6]. This linkage is conserved in the mouse.a number of endocrine/paracrine pathways that are
One condition in which the dosage of imprinted genesimportant for normal mammalian development. Here,
is perturbed is UPD, defined as the presence, in a diploidwe show that an endocrine/paracrine pathway involv-
individual, of both homologs of one chromosome pairing thyroid hormone metabolism is also regulated by
from only one parent [7]. Patients with maternal UPD forimprinting. Thyroid hormone action depends on thy-
chromosome 14 (mUPD14) exhibit growth retardation,roid hormone receptors and their predominant ligand,
developmental delay, and precocious puberty, while pa-3,5,3-triiodothyronine (T3). In vivo, thyroid hormone
ternal UPD14 (pUPD14) causes skeletal defects andlevels are maintained within the physiological range
mental retardation [8]. Some of these defects are consis-through the interaction of three iodothyronine deiodi-
tent with the phenotypes described for the mUPD12 andnases, D1, D2, and D3. D3 inactivates thyroxine (T4)
pUPD12 mice [9]. The mouse Dio3 gene on chromosomeand T3 by 5-deiodination, and the gene for this enzyme,
12 was thus analyzed as a candidate for imprinting withDio3, lies in the imprinted domain on human chromo-
the potential to contribute to the UPD12 phenotypessome 14q32/distal mouse chromosome 12. Here, we
through its regulation of thyroid hormones.report the imprinting of Dio3, which is expressed pref-
In mice, the coding region and known 5-UTR anderentially from the paternal allele. No differentially
3-UTR of Dio3 are contained within a single exon en-methylated region was identified in the CpG-island
compassing 1853 nucleotides. Sequence analysis re-promoter, which is completely unmethylated. Local-
vealed that the region spanning the promoter and oneization of transcripts suggests that Dio3 may be ex-
third of the exon is a CpG island (Figure 1A). Northernerting its function in both endocrine and autocrine/
blots using RNA isolated from embryonic day 15.5paracrine manners. An assay was developed for T3,
(E15.5) normal, mUPD12, and pUPD12 conceptusesand we show that its levels in maternal and paternal
were probed with D3 (Figure 2A). Dio3 was expressed inuniparental disomy (UPD) 12 fetuses are reciprocally
pUPD12 embryos and placentas at a level approximatelyaffected. These results demonstrate that disruption of
twice that seen in normal embryos and placentas, andthe imprinting status of Dio3 results in abnormal thy-
it was significantly reduced to only half of the normalroid hormone levels and may contribute to the pheno-
level in mUPD12, suggesting that this gene is imprinted.typic abnormalities in UPD12 mice and UPD14 humans.
To confirm the imprinted expression of Dio3 in mUPD12
and pUPD12, a reverse transcription (RT)-PCR assay
Results and Discussion was developed to assess allele-specific expression of
Dio3 in normal conceptuses. A single nucleotide poly-
Genomic imprinting in mammals is an epigenetic pro- morphism (SNP), which abolishes the TaqI site in JF1
cess by which the two parental alleles of a gene are (Figure 2B), was identified in the 3-UTR between the
differentially expressed according to parental origin. C57BL/6J (B6) and Mus musculus molossinus (JF1)
This results in a functional asymmetry between the pa- strains. Total RNA was prepared from F1 embryos and
ternal and maternal genomes [1]. Imprinted genes tend whole placentas from four crosses (B6B6, designated
to be clustered in the genome, approximately 50 im- as B6; JF1  JF1, designated as JF1; JF1 female 
printed genes have been identified to date, and many B6 male, designated as JB; B6 female  JF1 male,
of them are involved in endocrine/paracrine pathways designated as BJ). After reverse transcription, PCR was
conducted to determine conditions adequate to mea-
sure the relative amount of the Dio3 transcript. The am-3 Correspondence: afsmith@mole.bio.cam.ac.uk
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Figure 1. Genomic Organization and Methyl-
ation Status of the Dio3 Gene
(A) CpG dinucleotide frequency (expressed
as a ratio of observed [Obs]/expected [Exp])
and the GC content (expressed as a percent-
age) are shown graphically (EMBL, CpGPlot).
Two regions (black bars) have the character-
istics of a CpG island. The numbers corre-
spond to the GenBank accession number
AF426023.
(B) The gene structure of Dio3 showing a sin-
gle exon that contains 1853 nucleotides. Red
bars, probes; arrows, positions of the primers
used in the RT-PCR analysis.
(C) A summary of the methylation analysis at
Dio3. The methylation status of the Hin6I sites
(above) and HpaII sites (below) was deter-
mined by Southern blot hybridization. Circles,
methylation status; white circles, unmethyl-
ated sites; partially filled circles, partially
methylated sites.
(D) Analysis of parental origin-specific meth-
ylation at Dio3. No differential methylation is
found in the embryo or placenta. The CpG
islands spanning the promoter and one third
of the exon are predominantly unmethylated
on both parental alleles in the embryo and
placenta. Genomic DNA prepared from nor-
mal, mUPD12, and pUPD12 embryos at E15.5
was digested with StuI (), further digested
with MspI (M), HpaII (H), or Hin6I (Hi), and
analyzed by Southern blot hybridization using
D1 as a probe (left). Genomic DNA, prepared
as above, was digested with PstI (), further
digested with MspI (M), HpaII (H), or Hin6I
(Hi), and analyzed by using probe D2 (right).
plification reaction proceeded in an exponential manner To determine whether the imprinting of Dio3 is associ-
ated with allele-specific methylation, DNA from UPD12until 35–40 cycles of PCR and then reached the plateau
phase (data not shown). Therefore, 32 cycles were used conceptuses was digested with methylation-sensitive
restriction enzymes. Systematic analysis of all the Hin6Ifor semiquantification. The RT-PCR products from the
F1 tissues were digested with TaqI and then separated and HpaII sites in the gene and its promoter revealed
no differentially methylated region in either the embryoon a 4% low-melting point (LMP) agarose gel (Figure
2C). The relative amount of the 97-bp diagnostic band or placenta (Figure 1C). Most of the Hin6I and HpaII sites
were completely unmethylated, including those in theto the internal control band was measured by densitom-
etry. The internal control band is representative of both promoter region, which is a CpG island (Figure 1D,
probe D1).parental alleles, while the diagnostic band is seen only
in the JF1 allele. The diagnostic band is evident in the D3 enzyme activity has been shown to be present in
the head, skin, limb, liver, and intestine in the fetal ratF1 embryo from the B6 female  JF1 male cross and
is virtually absent in the F1 embryo from the JF1 [10]. To further characterize Dio3 expression in tissues
and to assess whether the imprinting of Dio3 was associ-femaleB6 male cross, indicating that Dio3 is imprinted
and expressed preferentially from the paternal allele in ated with the phenotypes seen in UPD12 mice, in situ
hybridization was performed on whole mouse embryosthe embryo. In the placenta, approximately 33% of Dio3
expression came from the maternal allele. This may be and placentas at E15.5. Figure 3 shows the distribution
of the Dio3 transcript in saggital sections of normal E15.5due to relaxation of its imprinting in the placenta or to
contamination with maternal tissue, as Dio3 is ex- embryos. Dio3 transcripts are localized selectively to a
few areas of the head and body. In Figure 3A, strongpressed in the maternal decidua in the rat [10].
Brief Communication
1223
to the skeletal muscle in the tongue, the skeletal muscle
around the digits also expressed Dio3 (Figure 3E, [e]).
It is known that thyroid hormones and their receptors
are involved in the maturation of cardiac and skeletal
muscles [12–14]. Therefore, disruption of Dio3 im-
printing in the skeletal muscles may be associated with
the reciprocal defects in myofiber maturation observed
in maternal and paternal UPD12 mice [9]. Furthermore,
we found that Dio3 was expressed in the mesenchyme
of the frontal region, upper lip, and lower jaw (Figure
3B, [b] and [c]). The mesenchyme of the tadpole has
been reported to induce metamorphic tissue remod-
elling under the influence of thyroid hormones [15]; how-
ever, the function of Dio3 in the mammalian mesen-
chyme is not known. Its potential role in the development
of the upper lip may be reflected in the reciprocally
abnormal philtrum length seen in mUPD14 and pUPD14
patients [8]. No specific signal was detected in the intes-
tine or kidney; however, the liver seemed to show a
general enhancement of the Dio3 signal, and strong
expression was evident in the gut mesentery (Figure
3D, [d]). In the placenta, Dio3 was expressed within the
nonendothelial cells of the labyrinthine trophoblast (data
not shown). It is notable that the trophoblasts in mUPD12
also expressed Dio3, though at a lower level. Further
analysis will determine the precise role of Dio3 in the
placenta. In summary, Dio3 was not predominantly ex-Figure 2. Dio3 Expression Is Imprinted
pressed in tissues affected in UPD12 conceptuses, such(A) Dio3 is expressed preferentially from the paternal allele both in
as bones, most muscles, and glycogen cells of the pla-the embryo and placenta. PolyARNA (0.5g) prepared from normal
(N), mUPD12 (M), and pUPD12 (P) embryos and whole placentas at centa. Degradation of T3 by D3 contributes to the final
E15.5 was analyzed by Northern blot hybridization using probe D3 intracellular T3 level, and a proportion of the T3 can
(Figure 1B). RNA loading levels were quantitated with a probe for enter the neighboring tissues or circulatory system [16].
glyceraldehyde 3-phosphate dehydrogenase (Gapdh). Expression In light of the highly localized sites of Dio3 expression,
of Dio3 was 1.83  0.18 times stronger in pUPD12 embryos com-
it is likely that Dio3 may control the local intracellularpared to normal embryos, whereas the Dio3 transcript was signifi-
thyroid hormone concentrations in both endocrine andcantly reduced to approximately half (0.53  0.10) of the normal
level in mUPD12 embryos (n  4 for each group). Expression was autocrine/paracrine manners.
determined by densitometric analysis on a Storm 860 Phosphor The mechanisms by which thyroid hormones regulate
Imager (Amersham). developmental processes are not fully understood.
(B) The TaqI restriction map of the RT-PCR products (Figure 1B) However, their action depends on the presence of thy-
from the JF1 and B6 alleles. A SNP in the JF1 strain eliminates a
roid hormone receptors and their major ligand, T3 [17].TaqI site, producing the 97-bp diagnostic band (red bar). The 132-
The levels of thyroid hormones required for developmentbp and 129-bp fragments served as the internal control band (green
bars). and the timing of their appearance are critical, and expo-
(C) Analysis of the RT-PCR products from F1 embryos and whole sure of the embryo to excessive levels of these com-
placentas, after digestion with TaqI and electrophoresis on a 4% pounds can have deleterious effects [18–21]. Interest-
LMP agarose gel. The diagnostic band was obvious in the F1 embryo ingly, the serum levels of the active thyroid hormones,
from the BJ (B6 female  JF1 male) cross and was virtually missing
T4 and T3, are lower in the mammalian fetus than in thein the F1 embryo from the JB (JF1 female B6 male) cross, indicat-
mother during most of gestation [22]. This is mainly dueing that Dio3 is imprinted and expressed preferentially from the
paternal allele in the embryo. The ratio of the amount of the 97-bp to the fact that only minimal amounts of maternal T4
diagnostic band to that of the internal control band as measured and T3 are transferred to the fetus, and this has been
by densitometry indicated the extent of imprinting of Dio3. With attributed to the expression in the fetus and placenta
ratios of 28.29% in the BJ embryo and 5.39% in the JB embryo of Dio3 [23]. To determine whether Dio3 exerts its effect
relative to 33.11% in the JF1 embryo (n  4 for each group), the
on development by regulating thyroid hormone levels,expression of Dio3 was estimated to be 84% from the paternal
we measured serum total T3 levels in normal, mUPD12,allele and 16% from the maternal allele in the whole embryo. In the
and pUPD12 embryos at E15.5 and E18.5. Blood wasplacenta, the maternal allele accounted for approximately 33% of
Dio3 expression. collected by cardiac puncture, and serum total T3 con-
centrations were determined using a competitive ELISA
kit (Alpha Diagnostic). At E15.5, pUPD12 embryos had
labeling can be observed in the palate and tongue. It is significantly lower levels compared with normal and
suggested that adequate levels of thyroid hormones are mUPD12 embryos (246.39 versus 316.97 and 339.82 ng/
required for normal palatal development from studies dL, respectively), which is consistent with an increase
in which coadministration of thyroid hormones with in functional Dio3. These values were normalized to em-
2,3,7,8-tetrachlorodibenzo-p-dioxin was shown to in- bryonic mass because mUPD12 fetuses exhibit severe
growth retardation [9] (Figure 4). A reciprocal pattern ofcrease the incidence of a cleft palate [11]. In addition
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Figure 3. In Situ Hybridization on Sagittal Sections of E15.5 Normal Embryos Showing the Localization of Dio3 mRNA
(A–E) The PCR product corresponding to probe D3 (Figure 1B) was cloned into pCR II (Invitrogen). The plasmid was linearized and transcribed
appropriately to produce antisense and sense riboprobes. Hybridization with the D3 sense probe gave a negative background signal (data
not shown). (A), (C), and (E) show the haemotoxylin and eosin staining of the sections under low (25)-power light-field illumination. (B) and
(D) are dark-field photomicrographs of Dio3 mRNA in the head and abdominal regions from the sections in (A) and (C), respectively. (a)–(e)
indicate the regions viewed with dark-field microscopy under higher magnification (100). Li, liver; Ki, kidney; Bl, bladder. (The scale bar
represents 1 mm).
regulation is noted. mUPD12 embryos had significantly hormone levels. This may explain the skeletal abnormali-
ties described for pUPD12 mice [9], as disrupted utiliza-higher T3 levels than normal embryos, while pUPD12
embryos had lower levels at both E15.5 and E18.5. These tion of thyroid hormones has been shown to retard
growth and bone maturation [24]. As high circulating T3data indicate that the differential expression of Dio3 in
UPD12 conceptuses has perturbed circulating thyroid levels could be detrimental to immature tissues [25], the
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Figure 4. Fetal Serum Total T3 Levels per
Gram Weight of the Conceptus
Serum total T3 levels in normal, mUPD12, and
pUPD12 embryos at E15.5 and E18.5 were
normalized to embryonic weight. mUPD12
embryos had significantly higher levels than
normal embyros, while pUPD12 had lower
levels, indicating a reciprocal pattern of regu-
lation. (Mean SE; *p 0.05, Scheffe’s post-
hoc test). At E15.5, n 17, 3, and 5 for normal,
mUPD12, and pUPD12 embryos, respec-
tively. At E18.5, n  12, 5, and 1 for normal,
mUPD12, and pUPD12 embryos, respec-
tively. (The fetal lethality associated with
pUPD12 means that they are rarely recovered
at E18.5).
reciprocally regulated thyroid hormone levels in imprinted and expressed preferentially from the paternal
allele. Disruption of Dio3 dosage has resulted in abnor-mUPD12 and pUPD12 embryos described here seem to
be consistent with the “genomic conflict” theory, which mal thyroid hormone levels, which likely contribute to
UPD12/14 phenotypes in mouse and man. Dio3 is there-predicts that imprinted genes that increase the fitness
of the progeny are expressed from paternally derived fore a protein-coding imprinted gene in the Dlk1-Gtl2
imprinted cluster and extends the imprinted domain bychromosomes [26]. In this case, this is of further interest
if the Dio3 allele expressed from the paternally derived several hundred kilobases. This cluster contains multi-
ple non-coding RNA species [32], including a cluster ofchromosome is regulating the supply of maternal levels
of thyroid hormones to the fetus. small nucleolar RNAs [33], and these are all expressed
from the maternally derived chromosome. Dio3 im-Precocious puberty is one of the most consistent phe-
notypes associated with mUPD14; all five of the printing does not appear to be regulated by short-range
cis-acting differential methylation at its CpG-island pro-mUPD14 patients that were old enough to be assessed
underwent precocious puberty [8]. Puberty is a process moter. Further studies will determine the mechanism of
Dio3 imprinting in this large imprinted cluster.leading to physical and sexual maturation that involves
the development of secondary sexual characteristics
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